{
    "Trade/Device Name(s)": [
        "GE Blood Glucose Monitoring System 180",
        "GE Blood Glucose Monitoring System 182",
        "Rightest Blood Glucose Monitoring System GM280",
        "Rightest Blood Glucose Monitoring System GM280B"
    ],
    "Submitter Information": "Bionime Corporation",
    "510(k) Number": "K170143",
    "Predicate Device Reference 510(k) Number(s)": [
        "K143387"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW"
    ],
    "Summary Letter Date": "May 30, 2017",
    "Summary Letter Received Date": "June 7, 2017",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Rightest Blood Glucose Meter GM280",
        "Rightest Blood Glucose Meter GM280B",
        "GE Blood Glucose Meter 180",
        "GE Blood Glucose Meter 182"
    ],
    "Method(s)/Technology(ies)": [
        "Glucose oxidase electrochemical sensor"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Analyzer",
        "Meter",
        "System",
        "Test Strip",
        "Lancing Device",
        "Control Solution",
        "Lancets"
    ],
    "Document Summary": "FDA 510(k) summary for Bionime Rightest and GE Blood Glucose Monitoring Systems for quantitative glucose measurement in fresh capillary whole blood using glucose oxidase electrochemical sensors.",
    "Indications for Use Summary": "Quantitative measurement of glucose in fresh capillary whole blood from fingertip, forearm, or palm for single-user, home self-testing by people with diabetes; not for diagnosis, screening, or neonatal use.",
    "fda_folder": "Clinical Chemistry"
}